An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer

PURPOSE: Genexol-PM is a Cremophor EL–free formulation of low-molecular-weight, non-toxic, and biodegradable polymeric micelle-bound paclitaxel. We conducted a phase III study comparing the clinical efficacy and toxicity of Genexol-PM with conventional paclitaxel (Genexol). MATERIALS AND METHODS: Pa...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Res Treat
Asıl Yazarlar: Park, In Hae, Sohn, Joo Hyuk, Kim, Sung Bae, Lee, Keun Seok, Chung, Joo Seop, Lee, Soo Hyeon, Kim, Tae You, Jung, Kyung Hae, Cho, Eun Kyung, Kim, Yang Soo, Song, Hong Suk, Seo, Jae Hong, Ryoo, Hun Mo, Lee, Sun Ah, Yoon, So Young, Kim, Chul Soo, Kim, Yong Tai, Kim, Si Young, Jin, Mi Ryung, Ro, Jungsil
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Korean Cancer Association 2017
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5512366/
https://ncbi.nlm.nih.gov/pubmed/27618821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2016.289
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller